Contact us
Log in
Servier

Servier

Overview

Servier is a global pharmaceutical group governed by a Foundation. Relying on a solid geographical presence and revenue of €4.7 billion in 2020 achieved in 150 countries, Servier employs 22,500 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient’s voice at the heart of its activities, from research to support beyond the pill.


A leader in cardiology, the ambition of the Servier Group is to become a recognized and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology and immuno-inflammatory, and neuropsychiatric diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies.


Find out more on : www.servier.com.

Suresnes, Île-de-France, France
25 Faculty
6 Courses available
550 Reviews

Upcoming events

Clinical management of anxiety in depressed patients.
Psychiatry
Online
Webinar
Jan 20, 2022
10:00 AM

On-demand

Replay-Modern Type 2 Diabetes Care: Why SUs remain a cornerstone (3:00-4:30 PM)
Endocrinology - Diabetology - Nutrition
Online
Replay
4.6
Replay-Modern Type 2 Diabetes Care: Why SUs remain a cornerstone(10:00-11:30 AM)
Endocrinology - Diabetology - Nutrition
Online
Replay
4.6
Repetición - Tratamiento actual de la diabetes tipo 2: Por qué las sulfonilureas siguen siendo fundamentales?
Endocrinology - Diabetology - Nutrition
Online
E-learning
4.6

Faculty

Overview

Head of Department Diabetes Research Centre University of Leicester, Leicester, United Kingdom

Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, UK. Prof Kamlesh Khunti is Co-Director of the Leicester Diabetes Centre and leads a research group that is currently working on the early identification of, and interventions with, people who have cardiometabolic disease or who are at increased risk of developing cardiometabolic diseases. His work has influenced national and international guidelines on the screening and management of people with diabetes. Professor Khunti is also Director of the UK National Institute for Health Research (NIHR) in Applied Research Collaborations (ARC) East Midlands and Director of The Real-World Evidence Unit and Centre for BME Health. He is a NIHR Senior Investigator and Principal Investigator on several major national and international studies. He is the National NIHR ARC Theme Lead for Multimorbidity and Ethnicity and Diversity. He is also Honorary Visiting Professorial Fellow at the Department of General Practice, University of Melbourne, Australia.

Overview

Professor of Medicine and Therapeutics and Director, Hong Kong Institute of Diabetes and Obesity at the Chinese University of Hong Kong, Professor Chan is a clinician scientist committed to translating evidence to practice and developing novel solutions for unmet needs. In the early 1990s, she set up the Hong Kong Diabetes Register and multiple cohorts to define the epidemiology of diabetes in Chinese populations. She is currently a member of an NIH-funded Global Consortium to discover causal genes in type 2 diabetes in a multi-ethnic population.

As one of the first Asian investigators involved in large scale multicenter studies in diabetes since 1990s, she established the CUHK Diabetes Clinical Trial Centre to implement a large number of landmark studies, pragmatic trials and epidemiological surveys. She is a steering committee member of multicenter clinical trials including the ORIENT, EASIE, EXSCEL, ACE, FIDELIO, FIGARO which evaluate the effects of novel compounds on clinical outcomes in diabetes. She founded the Asia Diabetes Foundation to develop the first web-based Joint Asia Diabetes Evaluation (JADE) Program which uses logistics, collaborative care, and information technology to promote quality improvement and collaborative research, now implemented in 11 Asian countries.

Prof. Dan Stein
Psychiatrist
Overview

Dan J. Stein is Professor and Chair of the Dept of Psychiatry at the University of Cape Town, and Director of the South African Medical Research Council’s Unit on Risk & Resilience in Mental Disorders. Dan’s training includes doctoral degrees in clinical neuroscience and in philosophy, and a post-doctoral fellowship in psychopharmacology. He is a clinician-scientist whose work has long focused on anxiety and related disorders, including obsessive-compulsive spectrum conditions and posttraumatic stress disorder. He has also mentored a range of other research, with publications spanning basic neuroscience, through clinical research, and on to public mental health. His research has had considerable influence (as evidenced by a Google h-index > 140, perhaps the highest of any African scholar), as has his mentorship (as evidenced by the career success of his postgraduate students and fellows). Awards for his work include the Collegium Internationale Neuropsychopharmacologicum’s Max Hamilton Award for his contributions to psychopharmacology, and its Ethics in Psychopharmacology Award.

Overview

Professor Nemencio A. Nicodemus Jr. trained in Internal Medicine and Adult Endocrinology at the Philippine General Hospital. Currently, he works in the Department of Biochemistry & Molecular Biology in the University of the Philippines, College of Medicine. He is also a Clinical Professor in the Department of Medicine, Division of Endocrinology, Diabetes & Metabolism at the Philippine General Hospital

Reviews

Global Review
4.6 /5
Pedagogy
4.5 /5
Organisation
4.6 /5
Knowledge aquired
4.5 /5
Recommendation
4.7 /5
Dec 28, 2021
Ismehen B.
Dec 16, 2021
Jean-Luc K.
Dec 14, 2021
Mariam C.
Dec 8, 2021
Georges R.
Dec 6, 2021
Nadia A.
Dec 6, 2021
Guy François M.

Videos